Production & Manufacturing
Manufacturing

Manufacturing News

View news from other Pharmaceutical sectors:
76-90 of 2321 results
AstraZeneca, Takeda to develop MEDI1341 for Parkinson’s disease
AstraZeneca and Takeda Pharmaceutical have entered into an agreement to jointly develop and commercialise MEDI1341, an alpha-synuclein antibody currently in development as a potential treatment for Parkinson’s disease (PD).
Production & Manufacturing > Manufacturing > News
Celgene exercises option to extend strategic collaboration scope and term with Forma Therapeutics
Forma Therapeutics and Celgene announced an innovative R&D partnership in 2014 to pursue ground-breaking medicines in oncology and other therapeutic areas.
Production & Manufacturing > Manufacturing > News
Genmab, Seattle Genetics to co-develop tisotumab vedotin for solid tumors
Genmab and Seattle Genetics announced that Seattle Genetics has exercised its option to co-develop tisotumab vedotin.
Production & Manufacturing > Manufacturing > News
Daiichi Sankyo, Boston Pharmaceuticals sign deal for selective RET inhibitor for solid tumors
Daiichi Sankyo and Boston Pharmaceuticals have entered into a worldwide licensing agreement for Daiichi Sankyo's novel RET inhibitor, DS-5010.
Production & Manufacturing > Manufacturing > News
Xoma announces license agreements for gevokizumab and its IL-1 beta intellectual property portfolio
Xoma has licensed the global commercial rights to gevokizumab, a novel anti-IL-1 beta allosteric monoclonal antibody, to Novartis.
Production & Manufacturing > Manufacturing > News
Gilead Sciences to buy Kite Pharma for $11.9bn
By PBR Staff Writer
Biopharmaceutical firm Gilead Sciences has agreed to acquire US-based Kite Pharma for around $11.9bn.
Production & Manufacturing > Manufacturing > News
CF PharmTech raises $65m to accelerate development of its inhalation products and manufacturing capacity
CF PharmTech announced that it has raised $65M in a Series D financing. Future Industry Investment Fund, a private equity fund managed by SDIC Fund Management Corporation Limited (SDIC Fund Management), led the financing along with other prestigious healthcare investment groups in China.
Production & Manufacturing > Manufacturing > News
Samsung Bioepis’ Humira biosimilar Imraldi approved in Europe
By EBR Staff Writer
Samsung Bioepis' Imraldi, the anti-TNF biosimilar of Humira (adalimumab), has been approved by the European Commission (EC) for all indications of the AbbVie monoclonal antibody.
Production & Manufacturing > Manufacturing > News
European Commission approves Novartis breast cancer drug Kisqali
Novartis’ breast cancer drug Kisqal has secured authorisation from the European Commission for the treatment of advanced breast cancer.
Production & Manufacturing > Manufacturing > News
AstraZeneca, MedImmune, Ethris to develop mRNA therapies for respiratory diseases
By PBR Staff Writer
AstraZeneca and its research and development arm MedImmune have entered into five-year strategic research collaboration with Ethris to develop mRNA therapies for respiratory diseases.
Production & Manufacturing > Manufacturing > News
Ironwood’s Duzallo gets FDA approval for gout-associated hyperuricemia
By PBR Staff Writer
Ironwood Pharmaceuticals’ Duzallo has been approved by the US Food and Drug Administration (FDA) for the treatment of hyperuricemia in patients with uncontrolled gout.
Production & Manufacturing > Manufacturing > News
SK Capital to acquire Perrigo’s Israeli API business
By PBR Staff Writer
New York-based private investment firm SK Capital has agreed to acquire Perrigo API, the active pharmaceutical ingredients (API) business of Perrigo Company in Israel, for $110m in an all-cash deal.
Production & Manufacturing > Manufacturing > News
Celgene, Sutro revise 2014 immuno-oncology collaboration
By PBR Staff Writer
Celgene has revised the terms of its immuno-oncology collaboration with Sutro Biopharma, which was established in 2014.
Production & Manufacturing > Manufacturing > News
Roche agrees to sell eczema drug rights to Dermira
By PBR Staff Writer
Dermira has signed a licensing agreement with Roche to secure exclusive rights to lebrikizumab, a monoclonal antibody targeting interleukin 13 (IL-13), for atopic dermatitis and all other indications.
Production & Manufacturing > Manufacturing > News
Kite Pharma seeks European approval for Axicabtagene Ciloleucel
Kite Pharma has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for axicabtagene ciloleucel as a treatment for patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL), transformed follicular lymphoma (TFL), and primary mediastinal B-cell lymphoma (PMBCL) who are not eligible for autologous stem cell transplant.
Production & Manufacturing > Manufacturing > News
76-90 of 2321 results